Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 96

1.

Where do you think you are going? The NMDA-D1 receptor trap.

Cepeda C, Levine MS.

Sci STKE. 2006 May 2;2006(333):pe20. Review.

PMID:
16670371
2.

Dopamine and N-methyl-D-aspartate receptor interactions in the neostriatum.

Cepeda C, Levine MS.

Dev Neurosci. 1998;20(1):1-18. Review.

PMID:
9600386
3.

Direct interactions between NMDA and D1 receptors: a tale of tails.

Lee FJ, Liu F.

Biochem Soc Trans. 2004 Dec;32(Pt 6):1032-6. Review.

PMID:
15506956
4.

Oligomeric assembly of dopamine D1 and glutamate NMDA receptors: molecular mechanisms and functional implications.

Fiorentini C, Missale C.

Biochem Soc Trans. 2004 Dec;32(Pt 6):1025-8. Review.

PMID:
15506954
5.

NMDA receptor subunits: diversity, development and disease.

Cull-Candy S, Brickley S, Farrant M.

Curr Opin Neurobiol. 2001 Jun;11(3):327-35. Review.

PMID:
11399431
6.

Dopamine/glutamate interaction as studied by combining turning behaviour and c-Fos expression.

Morelli M.

Neurosci Biobehav Rev. 1997 Jul;21(4):505-9. Review.

PMID:
9195609
7.

The NMDA/D1 receptor complex as a new target in drug development.

Missale C, Fiorentini C, Busi C, Collo G, Spano PF.

Curr Top Med Chem. 2006;6(8):801-8. Review.

PMID:
16719818
8.
9.

Neurotensin receptor mechanisms and its modulation of glutamate transmission in the brain: relevance for neurodegenerative diseases and their treatment.

Antonelli T, Fuxe K, Tomasini MC, Mazzoni E, Agnati LF, Tanganelli S, Ferraro L.

Prog Neurobiol. 2007 Oct;83(2):92-109. Epub 2007 Jun 28. Review.

PMID:
17673354
10.

AMPA and NMDA glutamate receptor trafficking: multiple roads for reaching and leaving the synapse.

Groc L, Choquet D.

Cell Tissue Res. 2006 Nov;326(2):423-38. Epub 2006 Jul 18. Review.

PMID:
16847641
11.
12.

Surface trafficking of N-methyl-D-aspartate receptors: physiological and pathological perspectives.

Groc L, Bard L, Choquet D.

Neuroscience. 2009 Jan 12;158(1):4-18. doi: 10.1016/j.neuroscience.2008.05.029. Epub 2008 Jun 26. Review.

PMID:
18583064
13.
14.

Excitatory amino acids in health and disease.

Thomas RJ.

J Am Geriatr Soc. 1995 Nov;43(11):1279-89. Review.

PMID:
7594165
15.

N-methyl-D-aspartate receptor subtypes: multiple roles in excitotoxicity and neurological disease.

Waxman EA, Lynch DR.

Neuroscientist. 2005 Feb;11(1):37-49. Review.

PMID:
15632277
16.

D5 dopamine receptor knockout mice and hypertension.

Yang Z, Sibley DR, Jose PA.

J Recept Signal Transduct Res. 2004 Aug;24(3):149-64. Review.

PMID:
15521360
17.

Subunit- and site-specific pharmacology of the NMDA receptor channel.

Yamakura T, Shimoji K.

Prog Neurobiol. 1999 Oct;59(3):279-98. Review.

PMID:
10465381
18.

NMDA antagonists and neuropathic pain--multiple drug targets and multiple uses.

Chizh BA, Headley PM.

Curr Pharm Des. 2005;11(23):2977-94. Review.

PMID:
16178757
19.

Glutamate- and GABA-based CNS therapeutics.

Foster AC, Kemp JA.

Curr Opin Pharmacol. 2006 Feb;6(1):7-17. Epub 2005 Dec 22. Review.

PMID:
16377242
20.

Mechanism of action of antipsychotic drugs: from dopamine D(2) receptor antagonism to glutamate NMDA facilitation.

Laruelle M, Frankle WG, Narendran R, Kegeles LS, Abi-Dargham A.

Clin Ther. 2005;27 Suppl A:S16-24. Review.

PMID:
16198197

Supplemental Content

Support Center